The prevalence ofgrade III or IV osteoarthritis was detennined in 210 patients with chronic renal failure, of whom 94 were receiving chronic haemodialysis and 116 had functioning renal transplants. The prevalence of grade III or IV osteoarthritis was three times greater in patients under 65 than in a control population, and all but two affected patients also had erosion of subchondral bone in at least one affected joint.
chronic haemodialysis and 116 had functioning renal transplants. The prevalence of grade III or IV osteoarthritis was three times greater in patients under 65 than in a control population, and all but two affected patients also had erosion of subchondral bone in at least one affected joint. The excess of osteoarthritis was apparent in both the transplant recipients and those receiving haemodialysis. Over the age of 65 there was no significant difference in prevalence. Metabolic bone disease, including osteopenia, might contribute to the development of erosive osteoarthritis in chronic renal failure.
We recently reported two cases, one a patient receiving chronic haemodialysis and the other a renal transplant recipient, who had developed severe progressive erosive osteoarthritis (OA) of the hands before the age of 35.' Previous studies of patients receiving chronic haemodialysis have noted degenerative changes in the small joints of hands but have not established whether this is in some way related to chronic renal failure or is simply related to age '9 
Results
The prevalence of grade III or IV OA amongst the renal patients (chronic haemodialysis and transplant recipients combined) aged 15-64 years (9-4%) was significantly higher than in the normal population (3%) (p<0-001). Over the age of 65, however, the number of renal patients available for study was small (19 total), and in this group there was no significant difference in prevalence of OA compared with controls. The sex ratios (female to male) in the transplant recipients, those receiving chronic haemodialysis, and controls were 2-9, 1-64, and 1-86 respectively.
Analysis of prevalence by decennial cohorts (24-34; 35-44; 45-54; 55-64; >65 years) showed that compared with the control data there was an excess of grade III or IV OA among patients with renal disease in each cohort up to the age of 65. This excess was apparent in both the patients receiving chronic haemodialysis >25 years and the transplant recipients >35 years (table). The differences between the renal patients and control data reached significance in the age cohorts 35-44 (p<005) and 55-64 (p<0-05).
Of the 21 patients with grade III or IV OA, all had distal interphalangeal joint involvement, and in addition five and nine respectively had proximal interphalangeal joint and first carpometacarpal joint involvement. All but two of the 21 patients also had erosion of subchondral bone in at least one of the affected joints. In most patients the joints were affected in an asymmetrical fashion with articular abnormalities ranging from normal in some joints to severe destructive changes in others. Review of earlier hand radiographs showed that minor osteoarthritic changes often progressed rapidly to destructive erosive OA (figs 1-3 Surprisingly, Naidich concluded that the changes were not typical of OA because of the presence of osteopenia, cystic change, and sometimes soft tissue calcification. Goldstein et al7 also described 11 patients receiving chronic haemodialysis who had a chronic hand arthropathy with similar radiographic features but noted an absence of 'spurring'-that is, osteophytes, and thus also concluded that the condition is distinct from OA. In our study we specifically identified those patients with radiological grade III or IV OA, who by definition have prominent osteophytes, and our data confirm that there is an association between chronic renal failure and premature onset of severe OA. In addition, almost all our patients showed evidence of progression to erosion of subchondral bone typical of erosive OA.
Most authors have not commented on whether the above radiological changes result in functional loss, and only two reports suggest that significant symptoms or deformity may develop.4 7 We have found OA in the hands to be a significant source of symptoms and functional loss in patients with chronic renal failure.
A similar conclusion was drawn in a recent survey of dialysis related arthropathy undertaken in this hospital, which found that OA is a common cause of small joint stiffness and pain. 
